Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from BD (Becton, Dickinson and Company)

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
BD Announces Collaboration for At-Home Rapid Test for COVID-19
Aims to Pair BD Antigen Test with Scanwell Health Mobile App 
Tickers BDX
From PR Newswire
BD to Present at Upcoming Investor Conferences
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences: 
Tickers BDX
From PR Newswire
BD Announces Emergency Use Authorization, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test
New single test for the BD MAX™ System also shows ability to detect U.K., South African Variants 
Tickers BDX
From PR Newswire
BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance
- First fiscal quarter revenues of $5.315 billion grew 25.8% on a reported basis. On a currency-neutral basis, revenues increased 24.3%. 
Tickers BDX
From PR Newswire
First-of-its-Kind Randomized Clinical Trial Published in "The Lancet Infectious Diseases" Outlines Potential New Standard-Setting Best Practices for Peripheral IV Catheters
- There is robust evidence that the BD vascular care solution and skin antiseptic for peripheral intravenous catheters used in the CLEAN3 randomized clinical trial can help improve patient outcomes 
Tickers BDX
From PR Newswire
BD Names CEO Tom Polen as Chairman of the Board
Polen to Succeed Vince Forlenza Effective April 28 
Tickers BDX
From PR Newswire
BD Board Declares Dividend
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on March 31, 2021 to holders of record on March 10, 2021.... 
Tickers BDX
From PR Newswire
New Clinical Data Shows BD Antigen Test May Be More Selective In Detecting Infectious COVID-19 Patients Than Molecular Tests
Peer-Reviewed Study Suggests BD Antigen Test Likely to Be More Selective at Detecting Patients Who Are Shedding Infectious SARS-CoV-2 Virus 
Tickers BDX
From PR Newswire
BD Provides Updates To Its Fiscal 2021 Financial Outlook And Intends To Comment On Its Preliminary First Fiscal Quarter Revenue Performance During Today's Webcast At The 39th Annual J.P. Morgan Health
- Preliminary first fiscal quarter 2021 revenues of $5.3 billion grew 25.6% on a reported basis. On a currency-neutral basis, revenues increased 24.2%, driven by higher base revenues in all three... 
Tickers BDX
From PR Newswire
BD to Present at the 39th Annual J.P. Morgan Healthcare Conference
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 39th Annual J.P. Morgan Healthcare Conference via webcast. BD's... 
Tickers BDX
From PR Newswire
BD Surpasses 1 Billion Injection Device Orders in Support of COVID-19 Vaccination Efforts Around the World
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pandemic orders for needles and syringes totaling more than 1 billion... 
Tickers BDX
From PR Newswire
New Clinical Trial Data Demonstrates BD Libertas™ Wearable Injector as a Drug Delivery System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced publication of the results from a 52-subject human clinical trial with the BD Libertas™... 
Tickers BDX
From PR Newswire
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade... 
Tickers BDX BDXB
From PR Newswire
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years
Investment includes new manufacturing facility in Europe 
Tickers BDX
From PR Newswire
BD Board Increases Dividend
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, an increase of 5.1% from the previous quarter. The dividend will be... 
Tickers BDX
From PR Newswire
BD Announces Streamlined Reporting Capabilities for COVID-19 Data
Reports Generated by BD Synapsys™ 3.84 Informatics Solution Simplify Mandatory Public Health Reporting 
Tickers BDX
From PR Newswire
BD to Present at Evercore ISI 3rd Annual HealthCONx Virtual Conference
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on... 
Tickers BDX
From PR Newswire
BD Acquires the Medical Business Assets of CUBEX LLC, Broadening Automated Dispensing Portfolio Across Care Continuum
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired the Medical Business assets of CUBEX LLC, which is a privately-held company... 
Tickers BDX
From PR Newswire
BD Announces Canadian Government Order of More Than 7 Million Portable, Rapid Point-of-Care Antigen Tests to Detect SARS-CoV-2 in 15 minutes
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has... 
Tickers BDX
From PR Newswire
BD to Present at Investor Virtual Healthcare Conferences
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming virtual healthcare conferences: 
Tickers BDX
From PR Newswire
BD Announces Fiscal Fourth Quarter And Full Year 2020 Results; Provides Fiscal 2021 Guidance
- Fiscal fourth quarter revenues of $4.784 billion grew 4.4% on a reported and currency-neutral basis. 
Tickers BDX
From PR Newswire
BD Receives Order from Dutch Ministry of Health for More than Nine Million 15-minute COVID-19 Antigen Tests
The first shipment of 1.2 million SARS-CoV-2 Assays for use on the BD Veritor™ Plus System to be delivered in The Netherlands by mid-November 
Tickers BDX
From PR Newswire
BD Announces Executive Leadership Appointments
Patrick Kaltenbach appointed chief technology officer 
Tickers BDX
From PR Newswire
CerTest Biotec and BD Announce CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX™ Molecular Diagnostic System
CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit... 
Tickers BDX
From PR Newswire
BD marks 25 years with Mercy Ships: Donates $1M to support launch of world's largest NGO hospital ship
Global Mercy will deliver free, world-class surgical care to patients in African nations who lack healthcare access 
Tickers BDX
From PR Newswire
BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System
BD FACSDuet™ Sample Preparation System, now available in the U.S., as the first fully automated sample-to-answer solution when integrated with the BD FACSLyric™ Flow Cytometer 
Tickers BDX
From PR Newswire
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2020 earnings conference call on Thursday, November... 
Tickers BDX
From PR Newswire
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October 
Tickers BDX
From PR Newswire
BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug... 
Tickers BDX
From PR Newswire
BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
Three Recalls Designated as Class I by FDA; One Designated as Class II 
Tickers BDX
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.